| ATP | Adenosine Triphosphate |
| CAR | Chimeric Antigen Receptor |
| CR | Complete Remission |
| CSF2RB | Colony Stimulating Factor 2 Receptor Beta |
| DLBCL | Diffuse Large B-Cell Lymphoma |
| ECAR | Extracellular Acidification Rate |
| FDA | Food and Drug Administration |
| FDR | False Discovery Rate |
| Gal-3 | Galectin-3 |
| GEO | Gene Expression Omnibus |
| GSEA | Gene Set Enrichment Analysis |
| HI-FBS | Heat-Inactivated Fetal Bovine Serum |
| IL-2 | Interleukin-2 |
| IL5RA | Interleukin-5 Receptor Alpha |
| JAK | Janus Kinase |
| MFI | Mean Fluorescence Intensity |
| MHC | Major Histocompatibility Complex |
| MOI | Multiplicity of Infection |
| NES | Normalized Enrichment Score |
| OCR | Oxygen Consumption Rate |
| PBMC | Peripheral Blood Mononuclear Cell |
| PD | Progressive Disease |
| PR | Partial Remission |
| qPCR | Quantitative Polymerase Chain Reaction |
| rhGal-3 | Recombinant Human Galectin-3 |
| RT-qPCR | Reverse Transcription Quantitative Polymerase Chain Reaction |
| scFv | Single-Chain Variable Fragment |
| SEM | Standard Error of the Mean |
| SNA | Sambucus nigra Agglutinin |
| SOCS1 | Suppressor of Cytokine Signaling 1 |
| SOCS3 | Suppressor of Cytokine Signaling 3 |
| STAT5 | Signal Transducer and Activator of Transcription 5 |
| STAT5A | Signal Transducer and Activator of Transcription 5A |
| STAT5B | Signal Transducer and Activator of Transcription 5B |
| ST6 | ST6GAL1-Overexpressing CAR-T Cells |
| ST6GAL1 | β-Galactoside α2,6-Sialyltransferase 1 |
| TanCAR | Tandem Chimeric Antigen Receptor |
| TME | Tumor Microenvironment |